Alliance A032002 (ART): Phase II randomized trial of atezolizumab versus atezolizumab and radiation therapy for platinum-ineligible/refractory metastatic urothelial cancer Meeting Abstract

  

Authors:	Nagar, H.; Ballman, K. V.; Tagawa, S. T.; Tan, A.; Faltas, B. M.; Sheybani, A.; Baghaie, S.; Schwartz, L. H.; Kozono, D. E.; Bogart, J. A.; Conway, O.; Mazza, G. L.; Chen, R. C.; Laccetti, A. L.; Rosenberg, J. E.; Morris, M. J.
Abstract Title:	Alliance A032002 (ART): Phase II randomized trial of atezolizumab versus atezolizumab and radiation therapy for platinum-ineligible/refractory metastatic urothelial cancer
Meeting Title:	2023 ASCO Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	41
Issue:	6 Suppl.
Meeting Dates:	2023 Feb 16-18
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2023-02-20
Language:	English
DOI:	10.1200/JCO.2023.41.6_suppl.TPS589
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=162007077&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	Meeting Abstract: TPS589 -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/203752